Trial | NCT02178137  Report issue

Title

Effect of Interventions on the Progression of Knee Osteoarthritis
Effect of Interventions on Progression of Knee Osteoarthritis - a Comparison of Effect of Glucosamine/Chondroitin or Diacerin Vs Placebo: Measured by Clinical, Radiological and Biochemical Parameters

  • Phase

    Phase 4

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    322
There has been intensive search for a substance that can have disease-modifying activity for osteoarthritis. A number of medications have been reported to be of benefit on slowing progression of knee OA. This trial will be the first head to head comparison of these medications.

Patients aged between age 40 to 65 will be enrolled. Patients will be assessed clinically using two scoring systems, the WOMAC index for knee arthritis and the SF 36 for overall physical and mental health. The knee X rays will be assessed on Kellgren and Lawrence grading and will also be measured for joint space narrowing at follow up. The response to arthritis medications on slowing down cartilage loss will be measured biochemically with COMP levels.
Study Started
Jun 30
2014
Primary Completion
Sep 30
2017
Study Completion
Oct 31
2017
Last Update
Mar 01
2018

Drug Diacerien

  • Other names: Artrodar, Dirtacetylrhein

Drug Glucosamine/Chondroitin

Drug Placebo

  • Other names: Zinc Sulphate

Glucosamine/Chondroitin Active Comparator

Glucosamine/Chondroitin twice a day for a daily total dose of 1500 mg of Glucosamine and 1200 mg of Chondroitin. Tablets will have 750 mg Glucosamine Sulphate and 600 mg of Chondroitin Sulphate. These will be taken twice a day after breakfast and dinner.

Diacerien Active Comparator

Diacerien 50 mg twice a day in capsule form. To be taken twice a day after breakfast and dinner

Placebo pill Placebo Comparator

Placebo tablets with Zinc sulfate twice a day. These will contain pharamacologically non active ingredients (Usually expedients).

Criteria 

Inclusion Criteria:

Patients of either sex aged between 40 to 65 years with mild to moderate osteoarthritis of the knees.
Patients should have history of knee pain for at least 6 months and on the majority of days during the preceding month
Each joint will be scored separately so one patient with bilateral knee osteoarthritis will be counted as 2 knees.
The osteoarthritis will be graded on basis of clinical score as well as seen on appropriately positioned x rays using the Kellgren and Lawrence grading. (Tibio femoral osteophytes of at least 1 mm, Kellgren Lawrence grading of 2 or 3)
Patients with diabetes are sent to the diabetes clinic and are included once their HbA1c level becomes normal.
Patients giving Informed consent

Exclusion Criteria:

Patients with severe end stage tricompartmental osteoarthritis of the knees .
Presence of uncontrolled systemic disease like chronic liver and renal disease
Patients with diagnosis other than osteoarthritis, such as knee arthritis due to rheumatoid disease, gout, post traumatic arthritis
Patients with history of surgery to any knee will have that knee excluded
Pregnant or lactating mothers
Patients with chronic anaemia
Patients who get an injection in their affected knee
No Results Posted